Richard Lane/Robert Holden Methadone Advocacy Award

Richard Lane was a long-term heroin user who, upon release from prison in 1967 helped to start Man Alive, one of the Nation’s first methadone treatment programs. In 1974, he became Executive Director of the program and later served as Vice President of the American Methadone Treatment Association. He served on several committees and was Vice Chairman of the Governor’s Council on Alcohol and Drug Abuse in Maryland. Richard was a passionate advocate for methadone treatment and, by disclosing his own treatment experiences, provided inspiration to patients and professionals alike.

He did more for advancing methadone treatment because he genuinely knew the subject and really, really cared about the underdog. Among the innovations he promoted within the methadone program were on-site alcoholism treatment, protocols for poly-drug abuse, services for patients with acquired immune deficiency syndrome, improved pain management for methadone patients, and fewer restrictions for socially rehabilitated patients on methadone including office based treatment which he did not enroll in himself. After a long and courageous battle with cancer, Richard Lane died in 1994.

Robert Holden was also a recovering heroin user and a friend of Richard Lane. He eventually became the Director of PIDARC, an outpatient methadone treatment program in the District Of Columbia. And he also served as the Vice President of the American Association for the Treatment of Opioid Dependence, succeeding Richard Lane’s term of office.

Robert was a different kind of advocate, he was not dynamic like Richard Lane. Robert was quieter but when needed he could speak about how methadone had saved his life and like Richard Robert used his own experience to get the point across. Robert Holden died in 2007 of Bone Marrow Cancer.

The award is presented at the AATOD Conference during the Awards Banquet by NAMA Recovery for AATOD. This award was established in 1995 and recognizes extraordinary achievements in patient advocacy.

Previous Awardees

1995 Richard Lane

2001 Joycelyn Woods

2007 Anthony Scro

2009 Walter Ginter

2010 Lisa Mojer-Torres

Instructions for Nominations

Deadline

The nominee and all the requested information must be submitted by Monday, August 22, 2011.

Criteria

  1. Only one (1) nominee can be submitted to the Conference Awards Committee. There may be a number of nominees, who will be fielded by NAMA Recovery in the medication assisted treatment MAT (i.e. methadone and/or buprenorphine) patient advocacy movement, however, NAMA Recovery will be responsible for submitting only one (1) “consensus” nominee to receive this honor.
  2. The nominee must have been involved in the field of methadone and/or buprenorphine advocacy for a period of five (5) years.
  3. The nominee must have been actively engaged in methadone and/or buprenorphine advocacy for a period of five (5) years.
  4. The nominee must have made meaningful and consistent contributions, which have had a significant impact on opioid treatment within a state or region of the United States.

Information to Submit

For each Nominee the NAMA Recovery Selection Committee must receive a “Completed Nomination Form”. A blank Nomination Form can be downloaded from this page.

At least 2 Letters of Support must accompany the Nomination Form. (you can submit more than 2)

The Letters of Support should detail the accomplishments and contributions made by the Nominee.

Where to Submit the Nominee Information

The Nomination Form and Letters of Support should be submitted to Joycelyn Woods at 

Suggestions for Persons Nominating an Advocate

  1. Start by contacting the person you want to nominate and tell them of your intentions. (not everyone may want to be nominated for an award)
  2. Ask them for their CV or Resume and use this to complete the Nomination Form.
  3. Ask the proposed awardee to suggest 2 persons to write Letters of Support.
  4. Send a copy of the Nomination Criteria to each person that will write a Letter of Support.
  5. Remind the 2 writers of the letters of support to send you the letters before the deadline.
  6. Send the completed Nomination Form to the proposed awardee and ask them to review it to make sure you have everything listed.
  7. Submit the Nomination Form and 2 Letters of Support by August 22, 2011.

If you have any questions contact: 

Download

Nomination Form

Criteria

Press Release

Return to Home Page

Similar Posts

  • Methadone 101

    Admin 08/10/2021

    The History of Methadone Maintenance Treatment The Discovery of Endorphins How Methadone Works 5. Methadone As Normal Medicine The History of Methadone Maintenance Treatment What is Methadone Maintenance Treatment? A) The most effective treatment for heroin and other opioid dependence? B) A means of reducing the transmission of the AIDS virus? C) The most progressive…

  • LAAM Warning

    Admin 07/05/2021

    FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…

  • CERTIFIED METHADONE ADVOCATE (CMA)-1

    Admin 02/22/2023

    The Advocacy Training Session The training for certification includes a variety of topics to give advocates a well-grounded understanding of methadone treatment, research, regulations and laws that protect methadone patients and programs. Addiction and Methadone The biological constructs of addiction will be explained in a way that can be understood by lay people (i.e. opiate receptors,…

  • NAMA-R NorthEast Recovery

    Admin 10/14/2022

    NAMA-R NorthEast Recovery Serving the New England Region Massachusetts, Maine, Rhode Island Connecticuit, New Hampshire and Vermont Welcome to Our Web Site! This website is for all Patients in Medication Assisted Treatment. NAMA-R NorthEast Recovery Includes Program Staff and Healthcare Professionals. We Believe That We Have A Lot To Offer Each Other. The National Alliance…

  • |

    Review Guidelines for the Federation of State Medical Boards

    Admin 10/20/2022

    NAMA’s Comments to the Federation of State Medical Boards Prepared by: National Alliance of Methadone Advocates 435 Second Avenue New York, NY 10010 Phone: (212) 595-6262 Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office Section I Preamble Paragraph 2 The second sentence should also include the fact that Medical Maintenance has been…

  • The President’s Office

    Admin 08/17/2022

    Methadone treatment is entering a new era giving methadone patients opportunities that they never had before. Our views and issues are being taken seriously by many and it is important that advocacy organizations continue their important role as the patient’s voice. It is because of the hard work of many of the NAMA chapters that…